Related references
Note: Only part of the references are listed.Synthesis, Anticancer Evaluation, Computer-Aided Docking Studies, and ADMET Prediction of 1,2,3-Triazolyl-Pyridine Hybrids as Human Aurora B Kinase Inhibitors
Huda R. M. Rashdan et al.
ACS OMEGA (2021)
Structural basis for the design of allosteric inhibitors of the Aurora kinase A enzyme in the cancer chemotherapy
Valeria Barbosa de Souza et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2020)
Synthesis, biological evaluation and molecular modeling study of 2-amino-3,5-disubstituted-pyrazines as Aurora kinases inhibitors
Yong-Xin Bo et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2020)
Design, synthesis, biological evaluation of 6-(2-amino-1H-benzo[d] imidazole-6-yl)quinazolin-4(3H)-one derivatives as novel anticancer agents with Aurora kinase inhibition
Chengcheng Fan et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Discovery and optimization of novel phenyldiazepine and pyridodiazepine based Aurora kinase inhibitors
Natarajan Tamizharasan et al.
BIOORGANIC CHEMISTRY (2020)
Synthesis and biological evaluation of nitroxide labeled pyrimidines as Aurora kinase inhibitors
You-Zhen Ma et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Design, synthesis, and biological evaluation of polyphenols with 4,6-diphenylpyrimidin-2-amine derivatives for inhibition of Aurora kinase A
Young Han Lee et al.
DARU-JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Optimization and biological evaluation of nicotinamide derivatives as Aurora kinase inhibitors
Baohui Qi et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2019)
Synthesis and identification of 2,4-bisanilinopyrimidines bearing 2,2,6,6-tetramethylpiperidine-N-oxyl as potential Aurora A inhibitors
Chun-Yan Sang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2019)
Synthesis and biological evaluation of 2,4-disubstituted phthalazinones as Aurora kinase inhibitors
Wei Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
Discovery and optimization of novel benzothiophene-3-carboxamides as highly potent inhibitors of Aurora kinases A and B
Pal Gyulavari et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Synthesis and biological evaluation of aurora kinases inhibitors based on N-trisubstituted pyrimidine scaffold
Liang Long et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Pyrazolo[4,3-b]pyrimido[4,5-e][1,4]diazepine derivatives as new multi-targeted inhibitors of Aurora A/B and KDR
Qiumeng Zhang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Structure-based drug design: Synthesis and biological evaluation of quinazolin-4-amine derivatives as selective Aurora A kinase inhibitors
Liang Long et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Benzimidazole - Schiff bases and their complexes: synthesis, anticancer activity and molecular modeling as Aurora kinase inhibitor
Asmaa A. Magd-El-Din et al.
ZEITSCHRIFT FUR NATURFORSCHUNG SECTION C-A JOURNAL OF BIOSCIENCES (2018)
The functional diversity of Aurora kinases: a comprehensive review
Estelle Willems et al.
CELL DIVISION (2018)
A comprehensive review on Aurora kinase: Small molecule inhibitors and clinical trial studies
Ankit C. Borisa et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Design, synthesis and biological activity of N4-phenylsubstituted-7H-pyrrolo[2,3-d]pyrimidin-4-amines as dual inhibitors of aurora kinase A and epidermal growth factor receptor kinase
Sonali Kurup et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2017)
Synthesis and structure elucidation of polyphenols containing the N-methyleneformohydrazide scaffold as aurora kinase inhibitors
Dongsoo Koh et al.
MAGNETIC RESONANCE IN CHEMISTRY (2017)
Optimization and biological evaluation of 2-aminobenzothiazole derivatives as Aurora B kinase inhibitors
Eun Lee et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Aurora kinase A is essential for correct chromosome segregation in mouse zygote
Veronika Kovarikova et al.
ZYGOTE (2016)
Design and synthesis of novel benzoxazole analogs as Aurora B kinase inhibitors
Ying An et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
3-Cyano-6-(5-methyl-3-pyrazoloamino) pyridines (Part 2): A dual inhibitor of Aurora kinase and tubulin polymerization
Masahiko Morioka
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Discovery of novel inhibitors of Aurora kinases with indazole scaffold: In silico fragment-based and knowledge-based drug design
Chun-Feng Chang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
The Aurora kinase inhibitors in cancer research and therapy
Jonas Cicenas
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2016)
Design and synthesis of imidazo[4,5-c]pyridine derivatives as promising Aurora kinase A (AURKA) inhibitors
D. A. Lomov et al.
RUSSIAN JOURNAL OF ORGANIC CHEMISTRY (2016)
Ubiquitin-Mediated Degradation of Aurora Kinases
Catherine Lindon et al.
FRONTIERS IN ONCOLOGY (2016)
New Benzimidazoles and Their Antitumor Effects with Aurora A Kinase and KSP Inhibitory Activities
Amira S. Abd El-All et al.
ARCHIV DER PHARMAZIE (2015)
Identification of novel inhibitors of Aurora A with a 3-(pyrrolopyridin-2-yl)indazole scaffold
Pinrao Song et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Expression Analysis of Aurora-C and Survivin, Two Testis-Specific Genes, in Patients with Colorectal Cancer
Saba Hosseini et al.
CLINICAL LABORATORY (2015)
Synthesis and biological evaluation of 2,4-diaminopyrimidines as selective Aurora A kinase inhibitors
Wen-Wen Qin et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Aurora kinase A gene copy number is associated with the malignant transformation of colorectal adenomas but not with the serrated neoplasia progression
Laura Casorzo et al.
HUMAN PATHOLOGY (2015)
Aurora kinase A in gastrointestinal cancers: time to target
Ahmed Katsha et al.
MOLECULAR CANCER (2015)
Benzo[e]pyrimido[5,4-b][1,4]diazepin-6(11H)-one derivatives as Aurora A kinase inhibitors: LQTA-QSAR analysis and detailed systematic validation of the developed model
Ashish M. Kanhed et al.
MOLECULAR DIVERSITY (2015)
Regulation of AURKC expression by CpG island methylation in human cancer cells
Satoshi Fujii et al.
TUMOR BIOLOGY (2015)
MLN8054 and Alisertib (MLN8237): Discovery of Selective Oral Aurora A Inhibitors
Todd B. Sells et al.
ACS MEDICINAL CHEMISTRY LETTERS (2015)
Cucurbitacin-I inhibits Aurora kinase A, Aurora kinase B and survivin, induces defects in cell cycle progression and promotes ABT-737-induced cell death in a caspase-independent manner in malignant human glioma cells
Daniel R. Premkumar et al.
CANCER BIOLOGY & THERAPY (2015)
Discovery of 4-aminoquinazoline-urea derivatives as Aurora kinase inhibitors with antiproliferative activity
Jin Cai et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Design, synthesis and bioevaluation of N-trisubstituted pyrimidine derivatives as potent aurora A kinase inhibitors
Yu Luo et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Aurora Kinase Inhibition Induces PUMA via NF-κB to Kill Colon Cancer Cells
Jing Sun et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Aurora kinase A mediates epithelial ovarian cancer cell migration and adhesion
T-V Do et al.
ONCOGENE (2014)
Contribution of Aurora-A and -B expression to DNA aneuploidy in gastric cancers
Kenichi Honma et al.
SURGERY TODAY (2014)
BUB1 mRNA is significantly co-expressed with AURKA and AURKB mRNA in advanced-stage ovarian serous carcinoma
Ben Davidson et al.
VIRCHOWS ARCHIV (2014)
Aurora kinase A suppresses metabolic stress-induced autophagic cell death by activating mTOR signaling in breast cancer cells
Ling-Zhi Xu et al.
ONCOTARGET (2014)
SAR and evaluation of novel 5H-benzo[c][1,8]naphthyridin-6-one analogs as Aurora kinase inhibitors
Srinivasa Karra et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Design, synthesis, quantum chemical studies and biological activity evaluation of pyrazole-benzimidazole derivatives as potent Aurora A/B kinase inhibitors
Youguang Zheng et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Stage I of a phase 2 study assessing the efficacy, safety, and tolerability of barasertib (AZD1152) versus low-dose cytosine arabinoside in elderly patients with acute myeloid leukemia
Hagop M. Kantarjian et al.
CANCER (2013)
Small Molecule Inhibitors of Aurora-A Induce Proteasomal Degradation of N-Myc in Childhood Neuroblastoma
Markus Brockmann et al.
CANCER CELL (2013)
BimEL is phosphorylated at mitosis by Aurora A and targeted for degradation by βTrCP1
M. Moustafa-Kamal et al.
CELL DEATH AND DIFFERENTIATION (2013)
3D-QSAR-Assisted Drug Design: Identification of a Potent Quinazoline-Based Aurora Kinase Inhibitor
Yi-Yu Ke et al.
CHEMMEDCHEM (2013)
Assessment of Aurora A kinase expression in breast cancer: A tool for early diagnosis?
Imen Ferchichi et al.
DISEASE MARKERS (2013)
Aurora B and Kif2A control microtubule length for assembly of a functional central spindle during anaphase
Ryota Uehara et al.
JOURNAL OF CELL BIOLOGY (2013)
Phosphorylation of NuMA by Aurora-A kinase in PC-3 prostate cancer cells affects proliferation, survival, and interphase NuMA localization
Raheleh Toughiri et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2013)
Aurora Isoform Selectivity: Design and Synthesis of Imidazo[4,5-b]pyridine Derivatives as Highly Selective Inhibitors of Aurora-A Kinase in Cells
Vassilios Bavetsias et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Optimization of Ligand and Lipophilic Efficiency To Identify an in Vivo Active Furano-Pyrimidine Aurora Kinase Inhibitor
Hui-Yi Shiao et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
AURKA Governs Self-Renewal Capacity in Glioma-Initiating Cells via Stabilization/Activation of β-catenin/Wnt Signaling
Zhibo Xia et al.
MOLECULAR CANCER RESEARCH (2013)
Aurora-B overexpression is correlated with aneuploidy and poor prognosis in non-small cell lung cancer
Masafumi Takeshita et al.
LUNG CANCER (2013)
New mitotic regulators released from chromatin
Hideki Yokoyama et al.
FRONTIERS IN ONCOLOGY (2013)
Aurora kinase A inhibition-induced autophagy triggers drug resistance in breast cancer cells
Zhengzhi Zou et al.
AUTOPHAGY (2012)
Structure-based design of 2,6,7-trisubstituted-7H-pyrrolo[2,3-d]pyrimidines as Aurora kinases inhibitors
Jean-Yves Le Brazidec et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Synthesis, biological evaluation, and molecular docking studies of N,1,3-triphenyl-1H-pyrazole-4-carboxamide derivatives as anticancer agents
Xi Li et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Synthesis, SAR and biological evaluation of 1,6-disubstituted-1H-pyrazolo [3,4-d]pyrimidines as dual inhibitors of Aurora kinases and CDK1
Jean-Yves Le Brazidec et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Aurora B is regulated by acetylation/deacetylation during mitosis in prostate cancer cells
Maria Fadri-Moskwik et al.
FASEB JOURNAL (2012)
Phase II study of MLN8237 (alisertib), an investigational Aurora A kinase inhibitor, in patients with platinum-resistant or -refractory epithelial ovarian, fallopian tube, or primary peritoneal carcinoma
Ursula A. Matulonis et al.
GYNECOLOGIC ONCOLOGY (2012)
Molecular dynamics and free energy studies on Aurora kinase A and its mutant bound with MLN8054: insight into molecular mechanism of subtype selectivity
Ying Yang et al.
MOLECULAR BIOSYSTEMS (2012)
Gene Amplification and Overexpression of Aurora-C in Breast and Prostate Cancer Cell Lines
Ali Zekri et al.
ONCOLOGY RESEARCH (2012)
Nuclear Aurora B and cytoplasmic Survivin expression is involved in lymph node metastasis of colorectal cancer
Handan Tuncel et al.
ONCOLOGY LETTERS (2012)
Design, synthesis, and biological evaluation of pyrazolopyrimidine-sulfonamides as potent multiple-mitotic kinase (MMK) inhibitors (part I)
Lin Zhang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Phase I Assessment of New Mechanism-Based Pharmacodynamic Biomarkers for MLN8054, a Small-Molecule Inhibitor of Aurora A Kinase
Arijit Chakravarty et al.
CANCER RESEARCH (2011)
Characterization of Alisertib (MLN8237), an Investigational Small-Molecule Inhibitor of Aurora A Kinase Using Novel In Vivo Pharmacodynamic Assays
Mark G. Manfredi et al.
CLINICAL CANCER RESEARCH (2011)
AURORA B EXPRESSION AS A PROGNOSTIC INDICATOR AND POSSIBILE THERAPEUTIC TARGET IN ORAL SQUAMOUS CELL CARCINOMA
G. Pannone et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2011)
Aurora Kinase A expression is associated with lung cancer histological-subtypes and with tumor de-differentiation
Marco Lo Iacono et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Aurora Kinase A Promotes Ovarian Tumorigenesis through Dysregulation of the Cell Cycle and Suppression of BRCA2
Gong Yang et al.
CLINICAL CANCER RESEARCH (2010)
The selective Aurora B kinase inhibitor AZD1152 as a novel treatment for hepatocellular carcinoma
Arihiro Aihara et al.
JOURNAL OF HEPATOLOGY (2010)
MLN8054, an Inhibitor of Aurora A Kinase, Induces Senescence in Human Tumor Cells Both In vitro and In vivo
Jessica J. Huck et al.
MOLECULAR CANCER RESEARCH (2010)
Phase I Study of the Selective Aurora A Kinase Inhibitor MLN8054 in Patients with Advanced Solid Tumors: Safety, Pharmacokinetics, and Pharmacodynamics
Teresa Macarulla et al.
MOLECULAR CANCER THERAPEUTICS (2010)
ZM447439, a Novel Promising Aurora Kinase Inhibitor, Provokes Antiproliferative and Proapoptotic Effects Alone and in Combination with Bio- and Chemotherapeutic Agents in Gastroenteropancreatic Neuroendocrine Tumor Cell Lines
I. Georgieva et al.
NEUROENDOCRINOLOGY (2010)
Self-organization of intracellular gradients during mitosis
Brian G. Fuller
CELL DIVISION (2010)
The discovery of the potent aurora inhibitor MK-0457 (VX-680)
David Bebbington et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Stabilization of N-Myc Is a Critical Function of Aurora A in Human Neuroblastoma
Tobias Otto et al.
CANCER CELL (2009)
Aurora A Regulates Prometaphase Progression by Inhibiting the Ability of RASSF1A to Suppress APC-Cdc20 Activity
Su Jung Song et al.
CANCER RESEARCH (2009)
Development and Biological Evaluation of a Novel Aurora A Kinase Inhibitor
Teresa Sardon et al.
CHEMBIOCHEM (2009)
Expression of Aurora kinase A and B in normal and malignant cervical tissue: High Aurora A kinase expression in squamous cervical cancer
Nae-Fang Twu et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2009)
Aurora-A down-regulates IkappaBα via Akt activation and interacts with insulin-like growth factor-1 induced phosphatidylinositol 3-kinase pathway for cancer cell survival
Jin-e Yao et al.
MOLECULAR CANCER (2009)
Effects of the Aurora kinase inhibitor VX-680 on anaplastic thyroid cancer-derived cell lines
Yannick Arlot-Bonnemains et al.
ENDOCRINE-RELATED CANCER (2008)
Effects of the aurora kinase inhibitors AZD1152-HQPA and ZM447439 on growth arrest and polyploidy in acute myeloid leukemia cell lines and primary blasts
Elisabeth Walsby et al.
HAEMATOLOGICA (2008)
Mitotic kinase Aurora-A phosphorylates RASSF1A and modulates RASSF1A-mediated microtubule interaction and M-phase cell cycle regulation
R. Rong et al.
ONCOGENE (2007)
VX-680 inhibits Aurora A and Aurora B kinase activity in human cells
Rebecca K. Tyler et al.
CELL CYCLE (2007)
AZD1152, a novel and selective aurora B kinase inhibitor, induces growth arrest, apoptosis, and sensitization for tubulin depolymerizing agent or topoisomerase II inhibitor in human acute leukemia cells in vitro and in vivo
Jing Yang et al.
BLOOD (2007)
Mitotic drug targets and the development of novel anti-mitotic anticancer drugs
Mathias Schmidt et al.
DRUG RESISTANCE UPDATES (2007)
AZD1152, a selective inhibitor of Aurora B kinase, inhibits human tumor xenograft growth by inducing apoptosis
Robert W. Wilkinson et al.
CLINICAL CANCER RESEARCH (2007)
MLN8054, a small-molecule inhibitor of Aurora A, causes spindle pole and chromosome congression defects leading to aneuploidy
Kara Hoar et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Subcellular localization of the spindle proteins Aurora A, Mad2, and BUBR1 assessed by immunohistochemistry
Espen Burum-Auensen et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2007)
Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase
Mark G. Manfredi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Roles of aurora kinases in mitosis and tumorigenesis
Jingyan Fu et al.
MOLECULAR CANCER RESEARCH (2007)
Structure of the kinase domain of an imatinib-resistant Abl mutant in complex with the aurora kinase inhibitor VX-680
MA Young et al.
CANCER RESEARCH (2006)
Mechanism of Aurora B activation by INCENP and inhibition by Hesperadin
F Sessa et al.
MOLECULAR CELL (2005)
Aurora kinase inhibitor ZM447439 blocks chromosome-induced spindle assembly, the completion of chromosome condensation, and the establishment of the spindle integrity checkpoint in Xenopus egg extracts
BB Gadea et al.
MOLECULAR BIOLOGY OF THE CELL (2005)
Overexpression of Aurora-A potentiates HRAS-mediated oncogenic transformation and is implicated in oral carcinogenesis
M Tatsuka et al.
ONCOGENE (2005)
VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo
EA Harrington et al.
NATURE MEDICINE (2004)
The cellular geography of aurora kinases
M Carmena et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
TAC-1 and ZYG-9 form a complex that promotes microtubule assembly in C-elegans embryos
JM Bellanger et al.
CURRENT BIOLOGY (2003)
Phosphorylation by Aurora B converts MgcRacGAP to a RhoGAP during cytokinesis
Y Minoshima et al.
DEVELOPMENTAL CELL (2003)
Functional significance of the specific sites phosphorylated in desmin at cleavage furrow: Aurora-B may phosphorylate and regulate type III intermediate filaments during cytokinesis coordinatedly with Rho-kinase
A Kawajiri et al.
MOLECULAR BIOLOGY OF THE CELL (2003)
A Ran signalling pathway mediated by the mitotic kinase Aurora A in spindle assembly
MY Tsai et al.
NATURE CELL BIOLOGY (2003)
Molecular dynamics of aurora-A kinase in living mitotic cells simultaneously visualized with histone H3 and nuclear membrane protein importinα
K Sugimoto et al.
CELL STRUCTURE AND FUNCTION (2002)
Crystal structure of aurora-2, an oncogenic serine/threonine kinase
GMT Cheetham et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
APC/Fizzy-Related targets Aurora-A kinase for proteolysis
A Castro et al.
EMBO REPORTS (2002)
Cell-cycle-dependent regulation of human aurora a transcription is mediated by periodic repression of E4TF1
M Tanaka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Drosophila Aurora A kinase is required to localize D-TACC to centrosomes and to regulate astral microtubules
R Giet et al.
JOURNAL OF CELL BIOLOGY (2002)
Drosophila Aurora B kinase is required for histone H3 phosphorylation and condensin recruitment during chromosome condensation and to organize the central spindle during cytokinesis
R Giet et al.
JOURNAL OF CELL BIOLOGY (2001)
Chromosomal passengers and the (aurora) ABCs of mitosis
RR Adams et al.
TRENDS IN CELL BIOLOGY (2001)
Mitotic kinases as regulators of cell division and its checkpoints
EA Nigg
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
Myosin II regulatory light chain as a novel substrate for AIM-1, an Aurora/Ipl1p-related kinase from rat
M Murata-Hori et al.
JOURNAL OF BIOCHEMISTRY (2000)
INCENP binds the Aurora-related kinase AIRK2 and is required to target it to chromosomes, the central spindle and cleavage furrow
RR Adams et al.
CURRENT BIOLOGY (2000)
CYK-4:: A Rho family GTPase activating protein (GAP) required for central spindle formation and cytokinesis
V Jantsch-Plunger et al.
JOURNAL OF CELL BIOLOGY (2000)
Degradation of human Aurora2 protein kinase by the anaphase-promoting complex-ubiquitin-proteasome pathway
K Honda et al.
ONCOGENE (2000)
Share Paper
